Brugada Phenocopy Induced by BRAF and MEK Inhibitors in a Lung Adenocarcinoma.

Abstract excerpt

Management of patients with drug-induced type 1 Brugada pattern is complex and controversial. We report the case of a 66-year-old man affected by metastatic lung adenocarcinoma with type 1 Brugada phenocopy at electrocardiogram (ECG) after initiation of an oncological therapy with BRAF and MEK inhibitors.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Action Potentials
• Share to Adenocarcinoma of Lung
• Share to Brugada Syndrome